Skip to content
PICO Portalanswers from OpenAlex

Rifaximin for the treatment of active pouchitis: A randomized, double-blind, placebo-controlled pilot study

PaperCitations, authors & open-access status

Rifaximin for the treatment of active pouchitis: A randomized, double-blind, placebo-controlled pilot study is a paper indexed in PICO Portal from OpenAlex.

How many citations does Rifaximin for the treatment of active pouchitis: A randomized, double-blind, placebo-controlled pilot study have?

PICO Portalcitation count

Rifaximin for the treatment of active pouchitis: A randomized, double-blind, placebo-controlled pilot study has 118 citations in the OpenAlex counts PICO Portal stores.

When was Rifaximin for the treatment of active pouchitis: A randomized, double-blind, placebo-controlled pilot study published?

PICO Portalyear

Rifaximin for the treatment of active pouchitis: A randomized, double-blind, placebo-controlled pilot study has 2007 year in the PICO Portal index.

What is the open-access status of Rifaximin for the treatment of active pouchitis: A randomized, double-blind, placebo-controlled pilot study?

PICO Portaloa status

Rifaximin for the treatment of active pouchitis: A randomized, double-blind, placebo-controlled pilot study has closed oa status in the PICO Portal index.

What is the DOI of Rifaximin for the treatment of active pouchitis: A randomized, double-blind, placebo-controlled pilot study?

PICO Portaldoi

The DOI for Rifaximin for the treatment of active pouchitis: A randomized, double-blind, placebo-controlled pilot study is on the source record.

What is the PMID of Rifaximin for the treatment of active pouchitis: A randomized, double-blind, placebo-controlled pilot study?

PICO Portalpmid

The PMID for Rifaximin for the treatment of active pouchitis: A randomized, double-blind, placebo-controlled pilot study is on the source record.

What is the OpenAlex record for Rifaximin for the treatment of active pouchitis: A randomized, double-blind, placebo-controlled pilot study?

PICO Portalopenalex

The OpenAlex for Rifaximin for the treatment of active pouchitis: A randomized, double-blind, placebo-controlled pilot study is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial